Ally Bridge Group as of Sept. 30, 2022
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 39 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seagen | 8.4 | $13M | 93k | 136.83 | |
| Ultragenyx Pharmaceutical (RARE) | 5.9 | $9.0M | 217k | 41.41 | |
| Sanofi Sponsored Adr (SNY) | 5.8 | $8.7M | 230k | 38.02 | |
| Karyopharm Therapeutics (KPTI) | 5.5 | $8.3M | 1.5M | 5.46 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 5.1 | $7.7M | 743k | 10.36 | |
| Rocket Pharmaceuticals (RCKT) | 5.1 | $7.7M | 480k | 15.96 | |
| GSK Sponsored Adr (GSK) | 5.0 | $7.5M | 255k | 29.43 | |
| Amarin Corp Spons Adr New (AMRN) | 4.6 | $6.9M | 6.4M | 1.09 | |
| Alkermes SHS (ALKS) | 4.4 | $6.7M | 300k | 22.33 | |
| Mersana Therapeutics (MRSN) | 4.2 | $6.3M | 932k | 6.76 | |
| Syros Pharmaceuticals Com New (SYRS) | 3.7 | $5.6M | 868k | 6.44 | |
| Horizon Therapeutics Pub L SHS | 3.0 | $4.6M | 74k | 61.89 | |
| Medavail Holdings Ord | 3.0 | $4.6M | 5.9M | 0.78 | |
| Gossamer Bio (GOSS) | 3.0 | $4.5M | 377k | 11.98 | |
| Sana Biotechnology (SANA) | 2.9 | $4.4M | 735k | 6.00 | |
| Argenx Se Sponsored Adr (ARGX) | 2.9 | $4.3M | 12k | 353.02 | |
| Sage Therapeutics (SAGE) | 2.8 | $4.3M | 110k | 39.16 | |
| Allakos (ALLK) | 2.4 | $3.7M | 598k | 6.12 | |
| Adicet Bio (ACET) | 2.3 | $3.5M | 244k | 14.22 | |
| Galapagos Nv Spon Adr (GLPG) | 2.2 | $3.3M | 77k | 42.63 | |
| Repligen Corporation (RGEN) | 2.1 | $3.1M | 17k | 187.10 | |
| Cogent Biosciences (COGT) | 2.0 | $3.0M | 204k | 14.92 | |
| Isoplexis Corp | 1.7 | $2.6M | 1.5M | 1.72 | |
| Rapid Micro Biosystems Class A Com (RPID) | 1.5 | $2.3M | 700k | 3.23 | |
| Atea Pharmaceuticals (AVIR) | 1.4 | $2.0M | 360k | 5.69 | |
| Science 37 Holdings | 1.3 | $2.0M | 1.3M | 1.61 | |
| Aadi Bioscience (AADI) | 1.2 | $1.8M | 125k | 14.13 | |
| Nautilus Biotechnology (NAUT) | 1.2 | $1.7M | 824k | 2.12 | |
| Incyte Corporation (INCY) | 1.1 | $1.7M | 25k | 66.64 | |
| Intercept Pharmaceuticals In | 0.9 | $1.4M | 100k | 13.95 | |
| Nektar Therapeutics (NKTR) | 0.9 | $1.4M | 433k | 3.20 | |
| Vor Biopharma (VOR) | 0.7 | $1.0M | 255k | 3.98 | |
| Editas Medicine (EDIT) | 0.7 | $1.0M | 83k | 12.24 | |
| Clovis Oncology | 0.4 | $635k | 534k | 1.19 | |
| Selecta Biosciences (RNAC) | 0.4 | $548k | 334k | 1.64 | |
| Morphosys Sponsored Ads (MOR) | 0.3 | $478k | 95k | 5.03 | |
| Curis Com New | 0.1 | $185k | 264k | 0.70 | |
| Puma Biotechnology (PBYI) | 0.1 | $152k | 64k | 2.36 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $103k | 86k | 1.19 |
